Bank Of Montreal Exelixis, Inc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Exelixis, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 68,889 shares of EXEL stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,889

Previous 55,260 24.66%

Holding current value

$2.45 Million

Previous $1.31 Million 18.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $277,213 - $323,416	13,629 Added 24.66%	68,889 $1.55 Million
Q1 2024 May 13, 2024	BUY	$20.17 - $23.93 $313,320 - $371,728	15,534 Added 39.1%	55,260 $1.31 Million
Q4 2023 Feb 08, 2024	BUY	$19.25 - $24.13 $63,274 - $79,315	3,287 Added 9.02%	39,726 $953,000
Q3 2023 Nov 01, 2023	SELL	$19.04 - $22.74 $3.14 Million - $3.75 Million	-164,962 Reduced 81.91%	36,439 $796,000
Q2 2023 Aug 02, 2023	BUY	$18.17 - $20.48 $2.77 Million - $3.12 Million	152,269 Added 309.92%	201,401 $3.85 Million
Q1 2023 Jun 13, 2024	BUY	$16.3 - $19.41 $1.71 Million - $2.04 Million	104,959 Added 189.94%	160,219 $3.11 Million
Q4 2022 Feb 01, 2023	SELL	$14.96 - $17.39 $750,902 - $872,873	-50,194 Reduced 50.53%	49,132 $788,000
Q3 2022 Nov 10, 2022	BUY	$15.68 - $22.27 $988,012 - $1.4 Million	63,011 Added 173.51%	99,326 $1.57 Million
Q2 2022 Aug 11, 2022	BUY	$17.44 - $23.16 $31,758 - $42,174	1,821 Added 5.28%	36,315 $803,000
Q1 2022 May 12, 2022	SELL	$17.03 - $22.67 $726,533 - $967,147	-42,662 Reduced 55.29%	34,494 $774,000
Q4 2021 Feb 11, 2022	SELL	$15.84 - $21.88 $33.4 Million - $46.2 Million	-2,109,478 Reduced 96.47%	77,156 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $1.25 Million - $1.62 Million	-76,677 Reduced 3.39%	2,186,634 $45.6 Million
Q2 2021 Aug 12, 2021	BUY	$17.95 - $25.56 $40.6 Million - $57.9 Million	2,263,311 New	2,263,311 $40.6 Million

Others Institutions Holding EXEL

# of Institutions

468

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.4B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account